Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role STAT 1d
FDA approves atezolizumab combination for stage III colon cancer with deficient DNA mismatch repair News-Medical.Net 1d
Stuart therapeutics expands pipeline with corneal wound healing program Business Wire (Press Release) 2d
Analysts expect breakeven for Capricor Therapeutics, Inc. (NASDAQ:CAPR) before long Simply Wall St 2d